USPTO serial 99719206
MODEX
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- ZAVALA DIEK, JOSEPH MARCO
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MODEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jill Anderfuren
Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP550 West Adams Street, Suite 300Chicago, IL 60661United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for the prevention and treatment of cancer and infectious diseases | ACTIVE | — |
| 042 | Medical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy | ACTIVE | Apr 1, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ModeX Therapeutics, Inc.
- Other trademarks owned by ModeX Therapeutics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MODEX
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 1, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2026 | NWAP | NEW APPLICATION ENTERED | — |